rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Simcere Zaiming, Inc.

Other role

Company insider

Files Form 4 as: Other, NextCure.

In numbers

Trades disclosed
1
Buys
0
Sells
1
Bought
$0
Sold
$185K
Companies
1
Companies where not an officer
1
First trade
10 Aug 2026
Last trade
10 Aug 2026
Last filed
12 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
NXTC NextCureOther · Biotechnology · last 10 Aug 20260 buys · 1 sell

Activity over time

1 Aug – 1 Oct
101 Aug1 Sep1 Oct

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
10 Aug 2026filed 12 Aug 2026NXTC NextCureBiotechnologySEC FORM 4 Sold$185K30,000 at $6.16filing

News

NextCure, Inc. (NASDAQ:NXTC) Sees Significant Increase in Short InterestNXTC · dailypolitical.com · 14 Oct 2026

0 headlines in the last 90 days name Simcere Zaiming, Inc.; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

ADAR1 Capital Management, LLC10% owner · 10% owner at NextCure, filing Form 4 there in the last year
Stephen W. WebsterDirector · Director at NextCure, filing Form 4 there in the last year
John G. HoustonDirector · Director at NextCure, filing Form 4 there in the last year
Ellen FeigalDirector · Director at NextCure, filing Form 4 there in the last year
David S. KabakoffDirector · Director at NextCure, filing Form 4 there in the last year